Investment Highlights

  • A pharma based approach to developing cannabis products for medical
    and recreational markets
  • Leadership team with international relationships in the fast growing medical and recreational cannabis industry
  • Expertise developing innovative, effective and precise cannabidiol (CBD), terpene and tetrahydrocannabinol (THC) based products
  • Seeking to acquire or develop, best in class novel technologies
    and bring them to market
  • Financial partners with experience in funding and creating value for shareholders in cannabis companies
Corporate Presentation

Milestones

1

JAN 2017

Formed new Scientific Advisory Board (SAB) consisting of leading biopharma technology advisors
2

FEB 2017

Announced BURST technology - a breakthrough in oral delivery of cannabinoids
3

FEB 2017

Acquired 65% of Biolennia Labs, a Health Canada & FDA licensed lab.
Immediate Strategy

2017
Through MJ BioPharma

  • Develop our own unique extracts and custom formulations with unique processes and methodologies.
  • Develop and numerous edible and oil products for the Medical and Recreational space.

2017
Through Biolennia Labs

  • Carry out R&D, develop and isolate formulations for use in medical and recreational applications.
  • Currently in application process for a dealers license.

2018
Expansion

  • Build a California and Nevada-licensed genetics breeding facility with extraction systems.
  • Add a dispensary license with our extraction and genetics partners.
Canadian Market Estimate
5
Billion If Legalized
US Market Estimate
7.6
Billion In Sales (2016)
Market Key Facts

A revolution is taking place in North America and across the globe and the race to create a better, more sophisticated supply chain with medical grade, quality controlled, custom cannabis products is underway. MJ BioPharma is aiming to establish itself as a leader in this segment by acquiring and developing novel technologies with immediate term commercial applications.

Latest Corporate Releases

Vinergy Resources/MJ BioPharma Develops a Disruptive Solvent Based Extraction System

| Corporate News | No Comments
VANCOUVER, BC, March 16, 2017 / - Vinergy Resources Ltd. ("Vinergy" or the "Company")(CSE:VIN)(OTCQB:VNNYF) in conjunction with its proposed acquisition of MJ Biopharma (announced December 14, 2016) is pleased to...

Vinergy Resources/MJ BioPharma Announces Memorandum of Understanding with Namaste Technologies Inc.

| Corporate News | No Comments
VANCOUVER, BRITISH COLUMBIA--(Marketwired - March 14, 2017) - Vinergy Resources Ltd. ("Vinergy" or the "Company") (CSE:VIN)(CSE:VIN.CN)(OTCQB:VNNYF) in conjunction with its proposed acquisition of MJ Biopharma (announced December 14, 2016) is...

Vinergy Resources/MJ BioPharma Appoints Mr. Facundo Bacardi to Board of Directors

| Corporate News | No Comments
VANCOUVER, BRITISH COLUMBIA--(Marketwired - March 9, 2017) - Vinergy Resources Ltd. ("Vinergy" or the "Company") (CSE:VIN)(CSE:VIN.CN)(OTCQB:VNNYF) in conjunction with its proposed acquisition of MJ Biopharma (announced December 14, 2016) is...